Diabetes Home > Onglyza and Breastfeeding
Before taking Onglyza, nursing women should first consult their healthcare providers. It is not known whether this medication passes through breast milk in humans (it does in rats). If your healthcare provider recommends breastfeeding while taking Onglyza, be sure to watch for any side effects in your baby.
Is Onglyza Safe for Breastfeeding Women?
At this time, it is unknown if Onglyza™ (saxagliptin) is safe for use by breastfeeding women. The manufacturer of Onglyza states that this medication should be used cautiously in breastfeeding women. Therefore, you should talk with your healthcare provider before taking it if you are breastfeeding or plan to start.
Breastfeeding Risks With Onglyza
Although Onglyza is known to pass through breast milk in rats, it is unknown if the same is true for humans. It is also unknown if Onglyza exposure (through breast milk) would have any noticeable or negative effects on a breastfeeding child.
If your healthcare provider recommends that you take Onglyza while breastfeeding, be sure to watch for any symptoms or changes in your child.
Talking With Your Healthcare Provider
You should talk with your healthcare provider about breastfeeding while taking Onglyza. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision about breastfeeding and Onglyza that is right for you.